Overexpression of GAPDH in human lung cancers was described previously by Tokunaga et al [28] and there are many publications showing increased expression of GAPDH in breast [29], pancreatic [30] and cervical [31], [32] human cancers. This evidence concerns the gene GAPDH and cancer.